Vivian Zhu

Vivian Zhu is currently the Head of Product Development at MiNK Therapeutics, overseeing process and analytical development functions for native and engineered iNKT cell therapy pipelines. With a solid background in cell therapies, Vivian previously held key roles at Takeda, Qilu Pharmaceuticals, Cogent Biosciences, UCB, and Dana-Farber Cancer Institute. Vivian is currently pursuing a Master of Business Administration with a focus on Entrepreneurship, Innovation, and Technology at The Johns Hopkins University, while holding a Ph.D. & Mphil in Clinical Oncology from The University of Hong Kong and a Bachelor's Degree in Life Science from Wuhan University.